Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederike K Engels

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
Docetaxel administration schedule: from fever to tears? A review of randomised studiesFrederike K Engels, Jaap Verweij
Anti-Cancer Drugs|December 13, 2006
Alternative drug formulations of docetaxel: a reviewFrederike K Engels, Ron A A Mathot, Jaap Verweij
Anti-Cancer Drugs|December 1, 2005
Quantification of [3H]docetaxel in feces and urine: development and validation of a combustion methodFrederike K Engels, Dirk Buijs, Walter J Loos, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2007
Influence of ketoconazole on the fecal and urinary disposition of docetaxelFrederike K Engels, Walter J Loos, Ron A A Mathot, et al.
Therapeutic Drug Monitoring|July 12, 2018
Therapeutic Drug Monitoring of Methotrexate in Plasma Using Ultra High-Performance Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry: Necessary After Administration of Glucarpidase in Methotrexate IntoxicationsMidas B Mulder, Ruud Huisman, Frederike K Engels, et al.
Cancer Biology & Therapy|June 16, 2006
Influence of high-dose ketoconazole on the pharmacokinetics of docetaxelFrederike K Engels, Ron A A Mathot, Walter J Loos, et al.
Cancer Chemotherapy and Pharmacology|December 20, 2008
Application of prolonged microdialysis sampling in carboplatin-treated cancer patientsInge R H M Konings, Frederike K Engels, Stefan Sleijfer, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2007
Medicinal cannabis in oncologyFrederike K Engels, Floris A de Jong, Ron H J Mathijssen, et al.
Pharmacy World & Science : PWS|March 29, 2003
Neuropsychiatric side effects of interferon-alfa therapyArthur R Van Gool, Wim H J Kruit, Frederike K Engels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Medicinal cannabis in oncology practice: still a bridge too far?Floris A de Jong, Frederike K Engels, Ron H J Mathijssen, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
Docetaxel administration schedule: from fever to tears? A review of randomised studiesFrederike K Engels, Jaap Verweij
Anti-Cancer Drugs|December 13, 2006
Alternative drug formulations of docetaxel: a reviewFrederike K Engels, Ron A A Mathot, Jaap Verweij
Anti-Cancer Drugs|December 1, 2005
Quantification of [3H]docetaxel in feces and urine: development and validation of a combustion methodFrederike K Engels, Dirk Buijs, Walter J Loos, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2007
Influence of ketoconazole on the fecal and urinary disposition of docetaxelFrederike K Engels, Walter J Loos, Ron A A Mathot, et al.
Therapeutic Drug Monitoring|July 12, 2018
Therapeutic Drug Monitoring of Methotrexate in Plasma Using Ultra High-Performance Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry: Necessary After Administration of Glucarpidase in Methotrexate IntoxicationsMidas B Mulder, Ruud Huisman, Frederike K Engels, et al.
Cancer Biology & Therapy|June 16, 2006
Influence of high-dose ketoconazole on the pharmacokinetics of docetaxelFrederike K Engels, Ron A A Mathot, Walter J Loos, et al.
Cancer Chemotherapy and Pharmacology|December 20, 2008
Application of prolonged microdialysis sampling in carboplatin-treated cancer patientsInge R H M Konings, Frederike K Engels, Stefan Sleijfer, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2007
Medicinal cannabis in oncologyFrederike K Engels, Floris A de Jong, Ron H J Mathijssen, et al.
Pharmacy World & Science : PWS|March 29, 2003
Neuropsychiatric side effects of interferon-alfa therapyArthur R Van Gool, Wim H J Kruit, Frederike K Engels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Medicinal cannabis in oncology practice: still a bridge too far?Floris A de Jong, Frederike K Engels, Ron H J Mathijssen, et al.
Pageof 2